0001209191-21-004769.txt : 20210121 0001209191-21-004769.hdr.sgml : 20210121 20210121210012 ACCESSION NUMBER: 0001209191-21-004769 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210119 FILED AS OF DATE: 20210121 DATE AS OF CHANGE: 20210121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HILL NANCY LOUISE CENTRAL INDEX KEY: 0001780790 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38957 FILM NUMBER: 21543526 MAIL ADDRESS: STREET 1: C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION STREET 2: 1551 EASTLAKE AVE E STE 200 CITY: SEATTLE STATE: WA ZIP: 98102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adaptive Biotechnologies Corp CENTRAL INDEX KEY: 0001478320 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 270907024 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1551 EASTLAKE AVENUE EAST SUITE 200 CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: 206-659-0067 MAIL ADDRESS: STREET 1: 1551 EASTLAKE AVENUE EAST SUITE 200 CITY: SEATTLE STATE: WA ZIP: 98102 FORMER COMPANY: FORMER CONFORMED NAME: Adaptive TCR Corp DATE OF NAME CHANGE: 20091209 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-19 0 0001478320 Adaptive Biotechnologies Corp ADPT 0001780790 HILL NANCY LOUISE C/O ADAPTIVE BIOTECHNOLOGIES CORP. SUITE 200 SEATTLE WA 98102 0 1 0 0 EVP, Operations & Program Mana Common Stock 2021-01-19 4 M 0 2000 0.84 A 12000 D Common Stock 2021-01-19 4 M 0 23000 4.07 D 35000 D Common Stock 2021-01-19 4 S 0 25000 69.00 D 10000 D Common Stock 500 I By Ryan Hill (son) Common Stock 400 I By Brandon Hill (son) Common Stock 300 I By Connor Hill (son) Stock Option (Right to Buy) 0.84 2021-01-19 4 M 0 2000 0.00 D 2023-11-03 Common Stock 2000 0 D Stock Option (Right to Buy) 4.07 2021-01-19 4 M 0 23000 0.00 D 2025-04-17 Common Stock 23000 27000 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein. The option is fully vested and exercisable. /s/ Nancy Hill by Eric Billings, Attorney-in-Fact 2021-01-21